Adelene Q. Perkins
Net Worth

Last updated:

What is Adelene Q. Perkins net worth?

The estimated net worth of Ms. Adelene Q. Perkins is at least $23,319,333 as of 12 Sep 2023. She has earned $2,619,333 from insider trading and has received compensation worth at least $20,700,000 in Infinity Pharmaceuticals, Inc..

What is the salary of Adelene Q. Perkins?

Ms. Adelene Q. Perkins salary is $1,150,000 per year as Chairman & Chief Executive Officer in Infinity Pharmaceuticals, Inc..

How old is Adelene Q. Perkins?

Ms. Adelene Q. Perkins is 65 years old, born in 1960.

What stocks does Adelene Q. Perkins currently own?

As insider, Ms. Adelene Q. Perkins owns shares in one company:

Company Title Shares Price per share Total value
Infinity Pharmaceuticals, Inc. (INFI) Chairman & Chief Executive Officer 1,175,291 $0 $0

What does Infinity Pharmaceuticals, Inc. do?

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.

INFI logo
INFI
Infinity Pharmaceuticals, Inc.

Adelene Q. Perkins insider trading

Infinity Pharmaceuticals, Inc.

Ms. Adelene Q. Perkins has made 11 insider trades between 2007-2023, according to the Form 4 filled with the SEC. Most recently she sold 410,196 units of INFI stock worth $28,714 on 12 Sep 2023.

The largest trade she's ever made was exercising 768,133 units of INFI stock on 9 Sep 2023. As of 12 Sep 2023 she still owns at least 1,175,291 units of INFI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 410,196 $0.07 $28,714
Option
Restricted Stock Unit 768,133 N/A N/A
Option
Common Stock 768,133 N/A N/A
Sale
Common Stock 5,000 $2.82 $14,100
Sale
Common Stock 5,000 $2.78 $13,890
Sale
Common Stock 5,000 $10.93 $54,650
Sale
Common Stock 10,000 $12.81 $128,100
Sale
Common Stock 10,000 $12.18 $121,800
Sale
Common Stock 20,000 $16 $320,000
Sale
Common Stock 25,000 $16.5 $412,500
Sale
Common Stock 40,000 $14.83 $593,080
Sale
Common Stock 13,076 $20.5 $268,097
Sale
Common Stock 31,924 $20.81 $664,402
Option
Stock Option (right to buy) 122,103 $5.22 $637,744
Option
Common Stock 175,997 $7.1 $1,250,107
Purchase
Common Stock 25,000 $6.07 $151,800
Purchase
Common Stock 5,349 $4.99 $26,692
Purchase
Common Stock 44,651 $4.89 $218,343
Purchase
Common Stock 8,500 $7.95 $67,567
Purchase
Common Stock 700 $7.7 $5,390
Purchase
Common Stock 100 $5.7 $570
Purchase
Common Stock 21,941 $6.09 $133,533
Purchase
Common Stock 776 $5.91 $4,588
Purchase
Common Stock 10,000 $10.64 $106,430
Purchase
Common Stock 2,946 $10.88 $32,052
Purchase
Common Stock 2,500 $10.85 $27,133
Purchase
Common Stock 1,000 $10.95 $10,950
Purchase
Common Stock 4,000 $10.89 $43,564
Purchase
Common Stock 2,048 $10.98 $22,493
Purchase
Common Stock 10,248 $10.93 $112,041
Purchase
Common Stock 900 $11.07 $9,963

Infinity Pharmaceuticals key executives

Infinity Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: